Trade HCA Healthcare - HCA CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Trading Conditions
| Spread | 0.49 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026346% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.004124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
HCA Healthcare Inc ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Key Stats
| Prev. Close* | 256.94 |
| Open* | 255.19 |
| 1-Year Change* | 6.83% |
| Day's Range* | 252.29 - 255.72 |
| 52 wk Range | 215.96-304.86 |
| Average Volume (10 days) | 1.73M |
| Average Volume (3 months) | 28.78M |
| Market Cap | 66.53B |
| P/E Ratio | 12.22 |
| Shares Outstanding | 267.66M |
| Revenue | 63.16B |
| EPS | 20.34 |
| Dividend (Yield %) | 0.96556 |
| Beta | 1.65 |
| Next Earnings Date | Jan 25, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 5, 2023 | 252.29 | -2.70 | -1.06% | 254.99 | 256.08 | 252.12 |
| Dec 4, 2023 | 256.94 | 7.06 | 2.83% | 249.88 | 257.21 | 249.88 |
| Dec 1, 2023 | 252.11 | 3.16 | 1.27% | 248.95 | 253.30 | 248.32 |
| Nov 30, 2023 | 250.09 | 2.48 | 1.00% | 247.61 | 250.33 | 245.41 |
| Nov 29, 2023 | 248.79 | 2.83 | 1.15% | 245.96 | 250.22 | 245.96 |
| Nov 28, 2023 | 246.33 | -2.40 | -0.96% | 248.73 | 250.05 | 245.38 |
| Nov 27, 2023 | 251.18 | 1.00 | 0.40% | 250.18 | 252.76 | 250.17 |
| Nov 24, 2023 | 251.87 | -0.98 | -0.39% | 252.85 | 253.41 | 250.68 |
| Nov 22, 2023 | 252.67 | 4.57 | 1.84% | 248.10 | 253.21 | 248.10 |
| Nov 21, 2023 | 248.24 | 1.81 | 0.73% | 246.43 | 250.07 | 246.43 |
| Nov 20, 2023 | 248.12 | 4.58 | 1.88% | 243.54 | 250.40 | 243.54 |
| Nov 17, 2023 | 246.13 | 4.36 | 1.80% | 241.77 | 249.77 | 241.77 |
| Nov 16, 2023 | 240.14 | 0.43 | 0.18% | 239.71 | 241.74 | 238.33 |
| Nov 15, 2023 | 240.82 | 3.82 | 1.61% | 237.00 | 244.58 | 236.75 |
| Nov 14, 2023 | 237.34 | 1.08 | 0.46% | 236.26 | 238.58 | 233.01 |
| Nov 13, 2023 | 229.70 | -2.35 | -1.01% | 232.05 | 235.41 | 228.83 |
| Nov 10, 2023 | 232.50 | 5.34 | 2.35% | 227.16 | 234.12 | 225.87 |
| Nov 9, 2023 | 227.38 | -4.50 | -1.94% | 231.88 | 235.07 | 226.99 |
| Nov 8, 2023 | 231.49 | -0.53 | -0.23% | 232.02 | 234.93 | 231.23 |
| Nov 7, 2023 | 232.89 | 3.56 | 1.55% | 229.33 | 233.87 | 229.33 |
HCA Healthcare Events
| Time (UTC) | Country | Event |
|---|---|---|
| Wednesday, December 13, 2023 | ||
| Time (UTC) 12:00 | Country US
| Event HCA Healthcare Inc HCA Healthcare IncForecast -Previous - |
| Time (UTC) 12:00 | Country US
| Event HCA Healthcare Inc HCA Healthcare IncForecast -Previous - |
| Thursday, January 25, 2024 | ||
| Time (UTC) 13:30 | Country US
| Event Q4 2023 HCA Healthcare Inc Earnings Release Q4 2023 HCA Healthcare Inc Earnings ReleaseForecast -Previous - |
| Thursday, April 18, 2024 | ||
| Time (UTC) 19:00 | Country US
| Event HCA Healthcare Inc Annual Shareholders Meeting HCA Healthcare Inc Annual Shareholders MeetingForecast -Previous - |
| Friday, April 19, 2024 | ||
| Time (UTC) 12:30 | Country US
| Event Q1 2024 HCA Healthcare Inc Earnings Release Q1 2024 HCA Healthcare Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total revenue | 60233 | 58752 | 51533 | 51336 | 46677 |
| Revenue | 60233 | 58752 | 51533 | 51336 | 46677 |
| Cost of Revenue, Total | 9371 | 9481 | 8369 | 8481 | 7724 |
| Gross Profit | 50862 | 49271 | 43164 | 42855 | 38953 |
| Total Operating Expense | 51258 | 49086 | 44566 | 44329 | 40044 |
| Selling/General/Admin. Expenses, Total | 27685 | 26779 | 23874 | 24415 | 30033 |
| Depreciation / Amortization | 2969 | 2853 | 2721 | 2596 | 2278 |
| Unusual Expense (Income) | 78 | 12 | 295 | 211 | 9 |
| Other Operating Expenses, Total | 11155 | 9961 | 9307 | 8626 | |
| Operating Income | 8975 | 9666 | 6967 | 7007 | 6633 |
| Interest Income (Expense), Net Non-Operating | -1696 | -1453 | -1530 | -1781 | -1726 |
| Gain (Loss) on Sale of Assets | 1301 | 1620 | -7 | 18 | 428 |
| Net Income Before Taxes | 8580 | 9833 | 5430 | 5244 | 5335 |
| Net Income After Taxes | 6834 | 7721 | 4387 | 4145 | 3838 |
| Minority Interest | -1191 | -765 | -633 | -640 | -602 |
| Net Income Before Extra. Items | 5643 | 6956 | 3754 | 3505 | 3236 |
| Net Income | 5643 | 6956 | 3754 | 3505 | 3787 |
| Income Available to Common Excl. Extra. Items | 5643 | 6956 | 3754 | 3505 | 3236 |
| Income Available to Common Incl. Extra. Items | 5643 | 6956 | 3754 | 3505 | 3787 |
| Diluted Net Income | 5643 | 6956 | 3754 | 3505 | 3787 |
| Diluted Weighted Average Shares | 294.666 | 328.752 | 343.605 | 348.226 | 355.303 |
| Diluted EPS Excluding Extraordinary Items | 19.1505 | 21.1588 | 10.9253 | 10.0653 | 9.10772 |
| Diluted Normalized EPS | 15.8446 | 17.3181 | 11.6354 | 10.5034 | 8.25935 |
| Total Extraordinary Items | 551 | ||||
| Dividends per Share - Common Stock Primary Issue | 2.24 | 1.44 | 1.6 | 1.4 |
| Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|
| Total revenue | 16213 | 15861 | 15591 | 15497 | 14971 |
| Revenue | 16213 | 15861 | 15591 | 15497 | 14971 |
| Cost of Revenue, Total | 2417 | 2478 | 2423 | 2429 | 2320 |
| Gross Profit | 13796 | 13383 | 13168 | 13068 | 12651 |
| Total Operating Expense | 14121 | 13561 | 13157 | 13084 | 12828 |
| Selling/General/Admin. Expenses, Total | 7556 | 7277 | 7084 | 7055 | 6899 |
| Depreciation / Amortization | 769 | 763 | 756 | 750 | 749 |
| Unusual Expense (Income) | 0 | 0 | 0 | 0 | |
| Operating Income | 2092 | 2300 | 2434 | 2413 | 2143 |
| Interest Income (Expense), Net Non-Operating | -464 | -492 | -497 | -437 | -436 |
| Gain (Loss) on Sale of Assets | 2 | 1 | -15 | 1326 | -3 |
| Net Income Before Taxes | 1630 | 1809 | 1922 | 3302 | 1704 |
| Net Income After Taxes | 1275 | 1412 | 1543 | 2646 | 1344 |
| Minority Interest | -196 | -219 | -180 | -565 | -210 |
| Net Income Before Extra. Items | 1079 | 1193 | 1363 | 2081 | 1134 |
| Net Income | 1079 | 1193 | 1363 | 2081 | 1134 |
| Income Available to Common Excl. Extra. Items | 1079 | 1193 | 1363 | 2081 | 1134 |
| Income Available to Common Incl. Extra. Items | 1079 | 1193 | 1363 | 2081 | 1134 |
| Diluted Net Income | 1079 | 1193 | 1363 | 2081 | 1134 |
| Diluted Weighted Average Shares | 275.424 | 278.198 | 280.961 | 285.558 | 289.852 |
| Diluted EPS Excluding Extraordinary Items | 3.9176 | 4.28831 | 4.85121 | 7.28749 | 3.91234 |
| Dividends per Share - Common Stock Primary Issue | 0.6 | 0.6 | 0.6 | 0.56 | 0.56 |
| Diluted Normalized EPS | 3.91192 | 4.28551 | 4.89407 | 3.56647 | 3.9205 |
| Other Operating Expenses, Total | 3379 | 3043 | 2894 | 2850 | 2860 |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total Current Assets | 13643 | 13542 | 12333 | 11196 | 10213 |
| Cash and Short Term Investments | 908 | 1451 | 1793 | 621 | 502 |
| Cash & Equivalents | 908 | 1451 | 1793 | 621 | 502 |
| Total Receivables, Net | 8891 | 8095 | 7051 | 7380 | 6789 |
| Accounts Receivable - Trade, Net | 8891 | 8095 | 7051 | 7380 | 6789 |
| Total Inventory | 2068 | 1986 | 2025 | 1849 | 1732 |
| Other Current Assets, Total | 1776 | 2010 | 1464 | 1346 | 1190 |
| Total Assets | 52438 | 50742 | 47490 | 45058 | 39207 |
| Property/Plant/Equipment, Total - Net | 27640 | 26176 | 25223 | 24549 | 19757 |
| Property/Plant/Equipment, Total - Gross | 56822 | 53463 | 51341 | 49069 | 42965 |
| Accumulated Depreciation, Total | -29182 | -27287 | -26118 | -24520 | -23208 |
| Goodwill, Net | 9653 | 9540 | 8578 | 8269 | 7953 |
| Long Term Investments | 1204 | 886 | 810 | 564 | 594 |
| Other Long Term Assets, Total | 298 | 598 | 546 | 480 | 690 |
| Total Current Liabilities | 9902 | 9582 | 8704 | 7757 | 7569 |
| Accounts Payable | 4239 | 4111 | 3535 | 2905 | 2577 |
| Accrued Expenses | 5212 | 5234 | 4960 | 4707 | 4204 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 370 | 237 | 209 | 145 | 788 |
| Total Liabilities | 55205 | 51675 | 46918 | 47866 | 44157 |
| Total Long Term Debt | 37714 | 34342 | 30795 | 33577 | 32033 |
| Long Term Debt | 37135 | 33765 | 30301 | 33107 | 32033 |
| Minority Interest | 2694 | 2422 | 2320 | 2243 | 2032 |
| Other Liabilities, Total | 4895 | 5329 | 5099 | 4289 | 2523 |
| Total Equity | -2767 | -933 | 572 | -2808 | -4950 |
| Common Stock | 3 | 3 | 3 | 3 | 3 |
| Retained Earnings (Accumulated Deficit) | -2280 | -532 | 777 | -2351 | -4572 |
| Unrealized Gain (Loss) | -30 | 12 | 25 | 14 | 3 |
| Other Equity, Total | -460 | -416 | -527 | -474 | -384 |
| Total Liabilities & Shareholders’ Equity | 52438 | 50742 | 47490 | 45058 | 39207 |
| Total Common Shares Outstanding | 277.378 | 305.477 | 339.426 | 338.446 | 342.895 |
| Capital Lease Obligations | 579 | 577 | 494 | 470 | |
| Additional Paid-In Capital | 0 | 294 | |||
| Other Current Liabilities, Total | 81 |
| Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|
| Total Current Assets | 14294 | 13888 | 13541 | 13643 | 13481 |
| Cash and Short Term Investments | 891 | 862 | 842 | 908 | 999 |
| Cash & Equivalents | 891 | 862 | 842 | 908 | 999 |
| Total Receivables, Net | 9182 | 8713 | 8657 | 8891 | 8552 |
| Accounts Receivable - Trade, Net | 9182 | 8713 | 8657 | 8891 | 8552 |
| Total Inventory | 2030 | 2050 | 2085 | 2068 | 2009 |
| Other Current Assets, Total | 2191 | 2263 | 1957 | 1776 | 1921 |
| Total Assets | 54589 | 53594 | 52711 | 52438 | 51484 |
| Property/Plant/Equipment, Total - Net | 29196 | 28754 | 28085 | 27640 | 27075 |
| Property/Plant/Equipment, Total - Gross | 57772 | 56667 | 55463 | 54757 | 53730 |
| Accumulated Depreciation, Total | -30655 | -30023 | -29410 | -29182 | -28752 |
| Goodwill, Net | 9778 | 9641 | 9590 | 9653 | 9651 |
| Long Term Investments | 1121 | 1115 | 1176 | 1204 | 816 |
| Other Long Term Assets, Total | 200 | 196 | 319 | 298 | 461 |
| Total Current Liabilities | 12407 | 11545 | 11028 | 9902 | 9784 |
| Accounts Payable | 4139 | 3823 | 3769 | 4239 | 4161 |
| Accrued Expenses | 5715 | 5327 | 4881 | 5293 | 5405 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 2553 | 2395 | 2378 | 370 | 218 |
| Total Liabilities | 57066 | 55897 | 55206 | 55205 | 54854 |
| Total Long Term Debt | 36793 | 36537 | 36478 | 37714 | 37492 |
| Long Term Debt | 36793 | 36537 | 36478 | 37714 | 37492 |
| Minority Interest | 2834 | 2764 | 2727 | 2694 | 2592 |
| Other Liabilities, Total | 5032 | 5051 | 4973 | 4895 | 4986 |
| Total Equity | -2477 | -2303 | -2495 | -2767 | -3370 |
| Common Stock | 3 | 3 | 3 | 3 | 3 |
| Additional Paid-In Capital | |||||
| Retained Earnings (Accumulated Deficit) | -1989 | -1850 | -2028 | -2280 | -2781 |
| Unrealized Gain (Loss) | -34 | -28 | -25 | -30 | -32 |
| Other Equity, Total | -457 | -428 | -445 | -460 | -560 |
| Total Liabilities & Shareholders’ Equity | 54589 | 53594 | 52711 | 52438 | 51484 |
| Total Common Shares Outstanding | 268.967 | 272.932 | 275.94 | 277.378 | 283.904 |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 6834 | 7721 | 4387 | 4145 | 4389 |
| Cash From Operating Activities | 8522 | 8959 | 9232 | 7602 | 6761 |
| Cash From Operating Activities | 2969 | 2853 | 2721 | 2596 | 2278 |
| Non-Cash Items | -129 | -1112 | 846 | 949 | 61 |
| Cash Taxes Paid | 1175 | 2182 | 1002 | 849 | 872 |
| Cash Interest Paid | 1662 | 1502 | 1607 | 1914 | 1744 |
| Changes in Working Capital | -1152 | -503 | 1278 | -88 | 33 |
| Cash From Investing Activities | -3389 | -2643 | -3393 | -5720 | -3901 |
| Capital Expenditures | -4395 | -3577 | -2835 | -4158 | -3573 |
| Other Investing Cash Flow Items, Total | 1006 | 934 | -558 | -1562 | -328 |
| Cash From Financing Activities | -5656 | -6655 | -4677 | -1771 | -3075 |
| Financing Cash Flow Items | -1290 | -1071 | -866 | -757 | -714 |
| Issuance (Retirement) of Stock, Net | -7000 | -8215 | -441 | -1031 | -1530 |
| Issuance (Retirement) of Debt, Net | 3287 | 3255 | -3217 | 567 | -344 |
| Net Change in Cash | -543 | -342 | 1172 | 119 | -230 |
| Total Cash Dividends Paid | -653 | -624 | -153 | -550 | -487 |
| Foreign Exchange Effects | -20 | -3 | 10 | 8 | -15 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 1543 | 6834 | 4188 | 2844 | 1465 |
| Cash From Operating Activities | 1803 | 8522 | 5995 | 2975 | 1345 |
| Cash From Operating Activities | 756 | 2969 | 2219 | 1470 | 732 |
| Non-Cash Items | 546 | -129 | 666 | 488 | 467 |
| Cash Taxes Paid | 7 | 1175 | 931 | 609 | 3 |
| Cash Interest Paid | 574 | 1662 | 1329 | 777 | 408 |
| Changes in Working Capital | -1042 | -1152 | -1078 | -1827 | -1319 |
| Cash From Investing Activities | -1151 | -3389 | -2596 | -2050 | -845 |
| Capital Expenditures | -1197 | -4395 | -3072 | -1941 | -861 |
| Other Investing Cash Flow Items, Total | 46 | 1006 | 476 | -109 | 16 |
| Cash From Financing Activities | -725 | -5656 | -3818 | -1501 | 425 |
| Financing Cash Flow Items | -394 | -1290 | -812 | -587 | -417 |
| Total Cash Dividends Paid | -175 | -653 | -497 | -337 | -177 |
| Issuance (Retirement) of Stock, Net | -846 | -7000 | -5481 | -4783 | -2101 |
| Issuance (Retirement) of Debt, Net | 690 | 3287 | 2972 | 4206 | 3120 |
| Foreign Exchange Effects | 7 | -20 | -33 | -17 | -5 |
| Net Change in Cash | -66 | -543 | -452 | -593 | 920 |
| Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
|---|---|---|---|---|---|---|
| Hercules Holding II | Corporation | 25.746 | 68912077 | 0 | 2022-12-31 | |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 6.4942 | 17382362 | -397097 | 2023-06-30 | LOW |
| Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 4.0948 | 10960076 | -1935280 | 2023-06-30 | LOW |
| Sanders Capital, LLC | Investment Advisor | 4.0871 | 10939667 | 354323 | 2023-06-30 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 3.4854 | 9329023 | -37317 | 2023-06-30 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 3.3533 | 8975423 | 149750 | 2023-06-30 | LOW |
| T. Rowe Price Associates, Inc. | Investment Advisor | 2.0431 | 5468654 | -2217583 | 2023-06-30 | LOW |
| First Eagle Investment Management, L.L.C. | Investment Advisor/Hedge Fund | 1.7023 | 4556365 | -32653 | 2023-06-30 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.42 | 3800828 | -12133 | 2023-06-30 | LOW |
| JP Morgan Asset Management | Investment Advisor | 1.3726 | 3673874 | 8827 | 2023-06-30 | LOW |
| Harris Associates L.P. | Investment Advisor/Hedge Fund | 1.1258 | 3013323 | -1925369 | 2023-06-30 | LOW |
| Arrowstreet Capital, Limited Partnership | Investment Advisor/Hedge Fund | 1.1186 | 2993971 | 1531395 | 2023-06-30 | MED |
| Longview Partners LLP | Investment Advisor/Hedge Fund | 0.9494 | 2541230 | -61602 | 2023-06-30 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.8518 | 2279978 | 227886 | 2022-12-31 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 0.6462 | 1729670 | -2084 | 2023-06-30 | LOW |
| RBC Global Asset Management (UK) Limited | Investment Advisor | 0.6097 | 1632016 | 1632016 | 2023-06-30 | LOW |
| Nuveen LLC | Pension Fund | 0.5939 | 1589508 | 44280 | 2023-06-30 | LOW |
| BlackRock Asset Management Ireland Limited | Investment Advisor | 0.5854 | 1566884 | -3457 | 2023-06-30 | LOW |
| Diamond Hill Capital Management Inc. | Investment Advisor/Hedge Fund | 0.5742 | 1536954 | -87189 | 2023-06-30 | LOW |
| Royal London Asset Management Ltd. | Investment Advisor/Hedge Fund | 0.5344 | 1430484 | 107029 | 2023-06-30 | MED |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
Leverage
1:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
HCA Healthcare Company profile
HCA Holdings Inc. (HCA) is an American provider of healthcare services, located in Nashville, Tennessee. Founded in1968, the company operates around 170 hospitals and 118 surgery centers offering medical, surgical, psychiatric, rehabilitation, and outpatient healthcare services. HCA Holdings operates in 20 US states and in the United Kingdom, and employs approximately 233,000 staff members. HCA Holdings Inc. is listed on the New York Stock Exchange (NYSE) and is an S&P 500 component. Get the Healthcare share price at Capital.com.| Industry: | Healthcare Facilities & Services (NEC) |
1 Park Plz
NASHVILLE
TENNESSEE 37203-6527
US
Income Statement
- Annual
- Quarterly
News
December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com